Reaction
Mitral Valve Disease reporting signals
As of the last recalculation, Mitral Valve Disease appears in 1,755 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is MESNA INJECTION (PRR 17.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mesna Injection | 12 | 17.3 | 17.4 |
| Mesna | 12 | 17.0 | 17.0 |
| Telmisartan | 24 | 16.2 | 16.2 |
| Linagliptin | 21 | 13.8 | 13.8 |
| Granisetron Hydrochloride | 12 | 13.7 | 13.7 |
| Digoxin | 67 | 11.5 | 11.5 |
| Ciclesonide | 13 | 11.4 | 11.4 |
| Granisetron | 10 | 11.4 | 11.4 |
| Thiotepa | 9 | 11.2 | 11.2 |
| Enalapril Maleate | 22 | 10.6 | 10.7 |
| Amlodipine Besylate And Benazepril Hydrochloride | 8 | 10.3 | 10.3 |
| Fenofibrate | 29 | 9.8 | 9.9 |
| Tiotropium Bromide Inhalation Spray | 9 | 9.6 | 9.6 |
| Glyburide | 19 | 9.4 | 9.4 |
| Warfarin Sodium | 36 | 9.4 | 9.4 |
| Bleomycin Sulfate | 8 | 9.2 | 9.2 |
| Warfarin | 84 | 8.2 | 8.2 |
| Vigabatrin | 10 | 8.2 | 8.2 |
| Oxybutynin Chloride | 6 | 8.1 | 8.1 |
| Carvedilol | 87 | 8.0 | 8.0 |
| Sotalol Hydrochloride | 11 | 7.9 | 7.9 |
| Bumetanide | 17 | 7.7 | 7.7 |
| Dutasteride | 5 | 7.3 | 7.3 |
| Erythropoietin | 12 | 7.0 | 7.0 |
| Pegaspargase | 7 | 6.8 | 6.8 |
| Dronedarone | 5 | 5.8 | 5.8 |
| Patiromer | 6 | 5.2 | 5.2 |
| Dofetilide | 4 | 4.5 | 4.5 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 4.3 | 4.3 |
| Sacubitril And Valsartan | 33 | 3.4 | 3.4 |
| Ambrisentan | 30 | 2.9 | 2.9 |
| Pegfilgrastim | 17 | 2.1 | 2.1 |